Related Experiment Video

Updated: Sep 28, 2026

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?

Nobuo Shinohara1, Tomohiko Koyanagi

  • 1nobuo-s@med.hokudai.ac.jp

Urological Research
|October 22, 2002
PubMed

Insights

Ras oncogenes drive human bladder cancer development and progression. Targeting Ras proteins offers a promising new therapeutic strategy for bladder cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Ras oncogenes are crucial in human bladder cancer's initiation and advancement.
  • Ras proteins function as intracellular molecular switches, regulating cell signaling pathways.
  • Aberrant Ras activation leads to uncontrolled cell growth and cancer progression.

Purpose of the Study:

  • To review the fundamental mechanisms of intracellular Ras signaling.
  • To examine the role of Ras activation in human bladder cancer.
  • To discuss the therapeutic potential of targeting Ras signaling in bladder cancer treatment.

Main Methods:

  • Review of current scientific literature on Ras signaling pathways.
  • Analysis of Ras oncogene involvement in bladder cancer carcinogenesis and progression.
  • Discussion of emerging therapeutic strategies targeting Ras.

Main Results:

  • Ras proteins are key mediators of mitogenic signaling in bladder cancer.
  • Constitutive Ras activation contributes to cellular transformation and tumor growth.
  • Several approaches to inhibit Ras activity are under investigation.

Conclusions:

  • Understanding Ras signaling is vital for developing effective bladder cancer therapies.
  • Inhibiting activated Ras function presents a viable therapeutic avenue.
  • Targeting Ras pathways holds significant clinical potential for bladder cancer treatment.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...